Monday, January 26, 2009

Analysts React to Pfizer’s Bid for Wyeth

Analysts say the acquisition helps deal with the Lipitor cliff, but doesn't do much for earnings growth.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)